168 related articles for article (PubMed ID: 36941789)
1. Beyond the amyloid hypothesis: how current research implicates autoimmunity in Alzheimer's disease pathogenesis.
Chatanaka MK; Sohaei D; Diamandis EP; Prassas I
Crit Rev Clin Lab Sci; 2023 Sep; 60(6):398-426. PubMed ID: 36941789
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer Disease Pathogenesis: The Role of Autoimmunity.
Lim B; Prassas I; Diamandis EP
J Appl Lab Med; 2021 Apr; 6(3):756-764. PubMed ID: 33241314
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal Fluid Total Tau Protein Correlates With Longitudinal, Progressing Cognitive Dysfunction in Anti-Neural Autoantibody-Associated Dementia and Alzheimer's Dementia: A Case-Control Study.
Hansen N; Juhl AL; Grenzer IM; Hirschel S; Teegen B; Fitzner D; Bartels C; Timäus C; Wiltfang J; Malchow B
Front Immunol; 2022; 13():837376. PubMed ID: 35309366
[TBL] [Abstract][Full Text] [Related]
4. The role of mitochondrial dysfunction in Alzheimer's disease pathogenesis.
Ashleigh T; Swerdlow RH; Beal MF
Alzheimers Dement; 2023 Jan; 19(1):333-342. PubMed ID: 35522844
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
6. Evidence that Brain-Reactive Autoantibodies Contribute to Chronic Neuronal Internalization of Exogenous Amyloid-β1-42 and Key Cell Surface Proteins During Alzheimer's Disease Pathogenesis.
Goldwaser EL; Acharya NK; Wu H; Godsey GA; Sarkar A; DeMarshall CA; Kosciuk MC; Nagele RG
J Alzheimers Dis; 2020; 74(1):345-361. PubMed ID: 32039847
[TBL] [Abstract][Full Text] [Related]
7. GABAergic dysfunction in excitatory and inhibitory (E/I) imbalance drives the pathogenesis of Alzheimer's disease.
Bi D; Wen L; Wu Z; Shen Y
Alzheimers Dement; 2020 Sep; 16(9):1312-1329. PubMed ID: 32543726
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel candidate autoantibodies in Alzheimer's disease.
Wang BZ; Zailan FZ; Wong BYX; Ng KP; Kandiah N
Eur J Neurol; 2020 Nov; 27(11):2292-2296. PubMed ID: 32356904
[TBL] [Abstract][Full Text] [Related]
9. The antimicrobial protection hypothesis of Alzheimer's disease.
Moir RD; Lathe R; Tanzi RE
Alzheimers Dement; 2018 Dec; 14(12):1602-1614. PubMed ID: 30314800
[TBL] [Abstract][Full Text] [Related]
10. Sex-Dependent Differences in Spontaneous Autoimmunity in Adult 3xTg-AD Mice.
Kapadia M; Mian MF; Michalski B; Azam AB; Ma D; Salwierz P; Christopher A; Rosa E; Zovkic IB; Forsythe P; Fahnestock M; Sakic B
J Alzheimers Dis; 2018; 63(3):1191-1205. PubMed ID: 29710702
[TBL] [Abstract][Full Text] [Related]
11. Filling the gaps in the abeta cascade hypothesis of Alzheimer's disease.
Golde TE; Dickson D; Hutton M
Curr Alzheimer Res; 2006 Dec; 3(5):421-30. PubMed ID: 17168641
[TBL] [Abstract][Full Text] [Related]
12. Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease.
Barage SH; Sonawane KD
Neuropeptides; 2015 Aug; 52():1-18. PubMed ID: 26149638
[TBL] [Abstract][Full Text] [Related]
13. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
[TBL] [Abstract][Full Text] [Related]
14. On the origin of Alzheimer's disease. Trials and tribulations of the amyloid hypothesis.
Castello MA; Soriano S
Ageing Res Rev; 2014 Jan; 13():10-2. PubMed ID: 24252390
[TBL] [Abstract][Full Text] [Related]
15. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
[TBL] [Abstract][Full Text] [Related]
16. [Evolution of the diagnostic frontiers of Alzheimer's disease and new therapeutic possibilities].
Gavrilova SI
Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(11. Vyp. 2):38-44. PubMed ID: 36412155
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's Disease: From Amyloid to Autoimmune Hypothesis.
Arshavsky YI
Neuroscientist; 2020; 26(5-6):455-470. PubMed ID: 32111138
[TBL] [Abstract][Full Text] [Related]
18. Dissecting the Contribution of Vascular Alterations and Aging to Alzheimer's Disease.
Janota C; Lemere CA; Brito MA
Mol Neurobiol; 2016 Aug; 53(6):3793-3811. PubMed ID: 26143259
[TBL] [Abstract][Full Text] [Related]
19. Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer's Disease Using Cerebrospinal Fluid Biomarkers in the AIBL Study.
Burnham SC; Coloma PM; Li QX; Collins S; Savage G; Laws S; Doecke J; Maruff P; Martins RN; Ames D; Rowe CC; Masters CL; Villemagne VL
J Prev Alzheimers Dis; 2019; 6(4):248-255. PubMed ID: 31686097
[TBL] [Abstract][Full Text] [Related]
20. Neurovascular dysfunction and vascular amyloid accumulation as early events in Alzheimer's disease.
Apátiga-Pérez R; Soto-Rojas LO; Campa-Córdoba BB; Luna-Viramontes NI; Cuevas E; Villanueva-Fierro I; Ontiveros-Torres MA; Bravo-Muñoz M; Flores-Rodríguez P; Garcés-Ramirez L; de la Cruz F; Montiel-Sosa JF; Pacheco-Herrero M; Luna-Muñoz J
Metab Brain Dis; 2022 Jan; 37(1):39-50. PubMed ID: 34406560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
